Viladomiu M, Metz ML, Lima SF, Jin W-B, Chou L, Guo C-J, Diehl GE, Simpson KW, Scherl EJ, Longman RS.
2021.
Adherent-invasive E. coli metabolism of propanediol in Crohn's disease regulates phagocytes to drive intestinal inflammation.. Cell Host Microbe. 29(4):607-619.e8.
Grigg JB, Shanmugavadivu A, Regen T, Parkhurst CN, Ahmed A, Joseph AM, Mazzucco M, Gronke K, Diefenbach A, Eberl G et al..
2021.
Antigen-presenting innate lymphoid cells orchestrate neuroinflammation.. Nature. 600(7890):707-712.
Danese S, Klopocka M, Scherl EJ, Romatowski J, Allegretti JR, Peeva E, Vincent MS, Schoenbeck U, Ye Z, Hassan-Zahraee M et al..
2021.
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study.. Clin Gastroenterol Hepatol. 19(11):2324-2332.e6.
De A, Chen W, Li H, Wright JR, Lamendella R, Lukin DJ, Szymczak WA, Sun K, Kelly L, Ghosh S et al..
2021.
Bacterial Swarmers Enriched During Intestinal Stress Ameliorate Damage.. Gastroenterology. 161(1):211-224.
Dohlman AB, Mendoza DArguijo, Ding S, Gao M, Dressman H, Iliev ID, Lipkin SM, Shen X.
2021.
The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants.. Cell Host Microbe. 29(2):281-298.e5.
Sandoval DA, Alonso LC, Gannon M, Sander M, Sussel L, Reusch JEB.
2021.
Career Advancement for Women in Diabetes-Related Research: Developing and Retaining Female Talent.. Diabetes Care. 44(8):1744-1747.
González-Borja I, Alors-Pérez E, Amat I, Alonso L, Viyuela-García C, Goñi S, Reyes JC, Ceballos-Chávez M, Hernández-García I, Sánchez-Frías ME et al..
2021.
Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma.. Front Med (Lausanne). 8:720128.
Shen B, Kochhar GS, Kariv R, Liu X, Navaneethan U, Rubin DT, Cross RK, Sugita A, D'Hoore A, Schairer J et al..
2021.
Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium.. Lancet Gastroenterol Hepatol. 6(10):826-849.
Goc J, Lv M, Bessman NJ, Flamar A-L, Sahota S, Suzuki H, Teng F, Putzel GG, Eberl G, Withers DR et al..
2021.
Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer.. Cell. 184(19):5015-5030.e16.